Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Mallinckrodt
Moodys
Colorcon
Dow

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Estetrol

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Estetrol: Patents, clinical trial progress, indications

Estetrol is an investigational drug.

There have been 19 clinical trials for Estetrol. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2016.

The most common disease conditions in clinical trials are Prostatic Neoplasms, Breast Neoplasms, and Hot Flashes. The leading clinical trial sponsors are Estetra, Pantarhei Bioscience, and Pantarhei Oncology B.V.

There are ninety-two US patents protecting this investigational drug and six hundred and fifty-seven international patents.

Recent Clinical Trials for Estetrol
TitleSponsorPhase
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal WomenICON Clinical ResearchPhase 3
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal WomenEstetraPhase 3
Effect of Food on the Bioavailability of 30 mg Estetrol (E4) Tablet in Healthy Postmenopausal Female VolunteersDonesta BiosciencePhase 1

See all Estetrol clinical trials

Clinical Trial Summary for Estetrol

Top disease conditions for Estetrol
Top clinical trial sponsors for Estetrol

See all Estetrol clinical trials

US Patents for Estetrol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Estetrol   See Pricing Synthesis of estetrol via estrone derived steroids Donesta Bioscience B.V. (Zeist, NL)   See Pricing
Estetrol   See Pricing Neuroprotection and myelin repair using Nestorone.RTM. The Population Council, Inc. (New York, NY)   See Pricing
Estetrol   See Pricing Gene fusions and gene variants associated with cancer LIFE TECHNOLOGIES CORPORATION (Carlsbad, CA)   See Pricing
Estetrol   See Pricing Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   See Pricing
Estetrol   See Pricing Tablet containing dehydroepiandrosterone (DHEA) PANTARHEI BIOSCIENCE B.V. (Zeist, NL)   See Pricing
Estetrol   See Pricing Apparatus and methods for drug delivery using multiple reservoirs CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Estetrol

Drugname Country Document Number Estimated Expiration Related US Patent
Estetrol Austria 469165 2022-11-08   See Pricing
Estetrol Australia 2003279624 2022-11-08   See Pricing
Estetrol Canada 2505190 2022-11-08   See Pricing
Estetrol China 100343269 2022-11-08   See Pricing
Estetrol China 1735627 2022-11-08   See Pricing
Estetrol Cyprus 1110237 2022-11-08   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Johnson and Johnson
AstraZeneca
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.